The Aga Khan University Hospital in Karachi, established in 1985, is the primary teaching site of the Aga Khan University's Faculty of Health Sciences. Founded by the Aga Khan, the hospital provides a broad range of secondary and tertiary care, including diagnosis of disease and team management of patient care.

During the past decade, Aga Khan University hospital conducted 47 clinical trials. In the 10-year time frame, 47 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Aga Khan University hospital" #1 sponsor was "Aga Khan University" with 41 trials, followed by "Aga Khan University Hospital, Pakistan" with 9 trials sponsored, "Dr. Stephen Freedman" with 2 trials sponsored, "KK Women's and Children's Hospital" with 2 trials sponsored and "Abeer Musaddiq" with 2 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Aga Khan University hospital" #1 collaborator was "Aga Khan University" with 5 trials as a collaborator, "Bill and Melinda Gates Foundation" with 2 trials as a collaborator, "Children's Hospital of Chongqing Medical University" with 2 trials as a collaborator, "Hyogo Prefectural Kobe Children's Hospital" with 2 trials as a collaborator and "King Chulalongkorn Memorial Hospital" with 2 trials as a collaborator. Other collaborators include 55 different institutions and companies that were collaborators in the rest 57 trials.

According to Clinical.Site data, the most researched conditions in "Aga Khan University hospital" are "Portal Hypertension" (3 trials), "Catheterization, Central Venous" (2 trials), "Coronavirus" (2 trials), "Dehydration" (2 trials) and "Diabetes Mellitus, Type 2" (2 trials). Many other conditions were trialed in "Aga Khan University hospital" in a lesser frequency.

Most popular intervention types in "Aga Khan University hospital" are "Drug" (34 trials), "Other" (12 trials), "Procedure" (11 trials), "Biological" (4 trials) and "Device" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Ondansetron" (2 trials), "Ropivacaine" (2 trials), "Terlipressin" (2 trials) and "5% fluoride varnish" (1 trials). Other intervention names were less common.

The vast majority of trials in "Aga Khan University hospital" are 66 trials for "All" genders, 4 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Aga Khan University hospital". undefined are not yet recruiting, 10 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 43 completed trials in Aga Khan University hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Aga Khan University hospital, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 24 trials that are defined as “Not Applicable".